Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges.

PMID: 41298848 ·

J, u, l, i, a, n, , H, e, r, p, e, r, t, z, ;, , A, r, i, e, l, , D, , S, t, e, r, n, ;, , N, i, l, s, , O, p, e, l, ;, , U, l, r, i, c, h, , R, e, i, n, i, n, g, h, a, u, s, ;, , J, o, h, n, , T, o, r, o, u, s

JournalNpj mental health research
Year
PMID41298848

Abstract

FDA approval is widely regarded as a benchmark of quality for medical devices. However, concerns persist regarding its regulatory framework for digital mental health devices. This perspective article examined FDA-authorized Software as a Medical Device (SaMD) in mental health, tracing the devices' regulatory lineage through the De Novo and 510(k)-clearance pathways while assessing the quality of evidence that led to their authorization. Many 510(k)-cleared devices lacked direct evidence of effec

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑